Adding the experimental inhaled therapy LAM-001 to ongoing treatment for PH-ILD may help reduce symptoms in a clinically ...

Scientists have created a new system to calculate the risk of short-term disease progression in people with pulmonary ...

For people living with pulmonary hypertension (PH), a "good day"can be one that is calm or simply manageable, writes columnist Jen Cueva.

As gasoline prices surge, that pressure could raise the cost of healthcare and prescription drugs, colunmist Mike Naple ...

Cereno will partner with PHA Europe & Global on patient-centered drug design for pulmonary hypertension medications.

Scientists in China used computer analyses to identify two genes driving pulmonary arterial hypertension that may prove a ...

Living with PH and transplant often involves a lack of privacy, but columnist Anna Jeter has found ways to preserve her ...

Tectonic sees top-line results from a Phase 2 trial of TX45 in PH with heart failure with preserved ejection fraction by ...

Mannkind and United Therapeutics are creating an inhaled formulation of ralinepag, an experimental oral PAH treatment.

Camp del Corazon and others are made for children with complex health conditions, writes columnist Jolie Lizana.

Although there is no cure yet for pulmonary hypertension (PH), there are a variety of therapies available that can help manage the symptoms of the disease and maintain or improve the quality of life ...

Treatment with mosliciguat, an inhaled medication given once-daily for pulmonary hypertension (PH), can safely reduce the resistance against blood flow in blood vessels of the lungs, according to a ...